CL2004001058A1 - HANDLE THAT HAS A FIRST AND SECOND END AND A WALL BETWEEN BOTH THAT EXTENDS DEFINING A TUBULAR CAVITY WHOSE INSIDE SIDE CONTAINS A THERAPEUTIC SECTION THAT PRESENTS A DOSED MOISTURE CONTROL SYSTEM WITH A FARMAC COMPOSITION - Google Patents

HANDLE THAT HAS A FIRST AND SECOND END AND A WALL BETWEEN BOTH THAT EXTENDS DEFINING A TUBULAR CAVITY WHOSE INSIDE SIDE CONTAINS A THERAPEUTIC SECTION THAT PRESENTS A DOSED MOISTURE CONTROL SYSTEM WITH A FARMAC COMPOSITION

Info

Publication number
CL2004001058A1
CL2004001058A1 CL200401058A CL2004001058A CL2004001058A1 CL 2004001058 A1 CL2004001058 A1 CL 2004001058A1 CL 200401058 A CL200401058 A CL 200401058A CL 2004001058 A CL2004001058 A CL 2004001058A CL 2004001058 A1 CL2004001058 A1 CL 2004001058A1
Authority
CL
Chile
Prior art keywords
farmac
dosed
presents
handle
composition
Prior art date
Application number
CL200401058A
Other languages
Spanish (es)
Inventor
Shane Smith
Joe Czerwinski
Don Moak
Blair Ramey
Mike Davies
Original Assignee
Signal Invest & Man Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34135037&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2004001058(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Signal Invest & Man Co filed Critical Signal Invest & Man Co
Publication of CL2004001058A1 publication Critical patent/CL2004001058A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • D—TEXTILES; PAPER
    • D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
    • D04B—KNITTING
    • D04B1/00—Weft knitting processes for the production of fabrics or articles not dependent on the use of particular machines; Fabrics or articles defined by such processes
    • D04B1/10—Patterned fabrics or articles
    • D04B1/102—Patterned fabrics or articles with stitch pattern
    • D—TEXTILES; PAPER
    • D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00—Medical; Hygiene
    • D10B2509/02—Bandages, dressings or absorbent pads
    • D10B2509/028—Elastic support stockings or elastic bandages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Textile Engineering (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE OFRECE UN NOVEDOSO ANALGESICO MICROENCAPSULADO DE USO TOPICO PARA EL TRATAMIENTO DEL DOLOR QUE PUEDE APLICARSE MEDIANTE MANGUITOS QUE TENGAN SECCIONES CON DOSIFICACION TERAPEUTICA ESPECIALMENTE INDICADO PARA ARTICULACIONES Y EXTREMIDADES. LOS MANGUITOS PUEDEN SEPARARSE GIRADOS DEL REVES PARA QUE EL USUARIO LOS INVIERTA AL COLOCARSELOS.A NEW MICROENCAPSULATED TOPICAL USE ANALGESIC IS OFFERED FOR THE TREATMENT OF PAIN THAT CAN BE APPLIED THROUGH SLEEVES THAT HAVE SECTIONS WITH SPECIFICALLY INDICATED THERAPEUTIC DOSAGE FOR ARTICULATIONS AND EXTREMITIES. THE SLEEVES CAN BE SEPARATED ROTATED REVERSELY FOR THE USER TO INVEST THEM BY PLACING THEM.

CL200401058A 2003-05-14 2004-05-14 HANDLE THAT HAS A FIRST AND SECOND END AND A WALL BETWEEN BOTH THAT EXTENDS DEFINING A TUBULAR CAVITY WHOSE INSIDE SIDE CONTAINS A THERAPEUTIC SECTION THAT PRESENTS A DOSED MOISTURE CONTROL SYSTEM WITH A FARMAC COMPOSITION CL2004001058A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47051303P 2003-05-14 2003-05-14

Publications (1)

Publication Number Publication Date
CL2004001058A1 true CL2004001058A1 (en) 2005-02-18

Family

ID=34135037

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401058A CL2004001058A1 (en) 2003-05-14 2004-05-14 HANDLE THAT HAS A FIRST AND SECOND END AND A WALL BETWEEN BOTH THAT EXTENDS DEFINING A TUBULAR CAVITY WHOSE INSIDE SIDE CONTAINS A THERAPEUTIC SECTION THAT PRESENTS A DOSED MOISTURE CONTROL SYSTEM WITH A FARMAC COMPOSITION

Country Status (10)

Country Link
US (2) US8282607B2 (en)
EP (1) EP1514539A3 (en)
AR (1) AR044350A1 (en)
AU (1) AU2004202050A1 (en)
BR (1) BRPI0401758A (en)
CL (1) CL2004001058A1 (en)
CO (1) CO5580153A1 (en)
MX (1) MXPA04004672A (en)
PE (1) PE20050108A1 (en)
SG (1) SG116546A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182739B2 (en) * 2005-05-12 2007-02-27 S.C. Johnson & Son, Inc. Therapy patch
US7485111B1 (en) * 2006-06-05 2009-02-03 Eugene Choi Medicated sleeve
US7282224B1 (en) 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
FR2913600B1 (en) * 2007-03-13 2011-02-25 Dbv Tech DEVICE FOR THE SKIN APPLICATION OF SUBSTANCES.
GB0814152D0 (en) * 2008-08-01 2008-09-10 Engineered Fibre Structures Lt Sleeve for trans-dermal patches
US8962057B2 (en) 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
WO2012174204A2 (en) 2011-06-17 2012-12-20 Fiberweb, Inc. Vapor permeable, substantially water impermeable multilayer article
PL2723568T3 (en) 2011-06-23 2018-01-31 Fiberweb Llc Vapor permeable, substantially water impermeable multilayer article
WO2012178027A2 (en) 2011-06-23 2012-12-27 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
WO2012178011A2 (en) 2011-06-24 2012-12-27 Fiberweb, Inc. Vapor-permeable, substantially water-impermeable multilayer article
US8697043B1 (en) 2013-01-08 2014-04-15 Chattem, Inc. Odor suppression of volatile organic analgesic compounds and method of use
HRP20211669T1 (en) * 2015-06-30 2022-02-18 Sequessome Technology Holdings Limited Multiphasic compositions
CA2993224A1 (en) * 2015-07-31 2017-02-09 Zen-Bio, Inc. Exosome compositions and use thereof for soft tissue repair
US11071717B2 (en) 2016-07-18 2021-07-27 Ana R. Olivero Anesthetic bandage
US10485835B2 (en) * 2016-11-18 2019-11-26 Drum Nerd Hand wrap including eucalyptus oil
US20200282280A1 (en) * 2019-03-06 2020-09-10 Kelly Wayne Stouffer Sports training garment for monitoring throwing motion of a thrower

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435180A (en) * 1982-05-25 1984-03-06 Alza Corporation Elastomeric active agent delivery system and method of use
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
DE4110087A1 (en) * 1991-03-27 1992-10-01 Fritz Dr Woerwag Benfotiamine-contg. pharmaceutical for topical use - is for treating e.g. rheumatic disorders, sciatica, lumbago, migraine etc. and other disorders beneficially affected by vitamin=B
AU3870895A (en) * 1994-11-14 1996-06-06 Zyma S.A. Use of menthyl lactate as a pain reliever
US6048326A (en) * 1996-12-31 2000-04-11 The Procter & Gamble Company Disposable elastic thermal knee wrap
DE19707322C1 (en) * 1997-02-12 1999-03-04 Cord Contract Research And Dev System for topical application of a pharmaceutical
US5758659A (en) * 1997-03-26 1998-06-02 Thompson; Robert B. Wound tab condom and method of application
FR2761886B1 (en) * 1997-04-14 2000-05-05 Virbac Sa COMPOSITIONS CONTAINING AT LEAST ONE CATIONIC POLYMER AND AT LEAST ONE ACTIVE MOLECULE CONTAINED IN AT LEAST ONE MICRO OR NANOPARTICLE VECTOR AND THEIR USE FOR THE TREATMENT OF LIVE OR INERT SURFACES
US6313370B1 (en) * 1999-04-29 2001-11-06 Morton Hyson Medicated wrap
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
US7012169B2 (en) * 2000-04-06 2006-03-14 Kimberly-Clark Worldwide, Inc. Disposable finger sleeve for appendages
US20030135171A1 (en) * 2002-01-14 2003-07-17 Ingram Aaron Neil Sleeve having integral and permanent therapeutic materials for application of a broad range of therapeutic modalities

Also Published As

Publication number Publication date
SG116546A1 (en) 2005-11-28
CO5580153A1 (en) 2005-11-30
EP1514539A3 (en) 2005-05-04
AR044350A1 (en) 2005-09-07
US8367100B2 (en) 2013-02-05
US20110004169A1 (en) 2011-01-06
PE20050108A1 (en) 2005-02-28
BRPI0401758A (en) 2005-03-22
AU2004202050A1 (en) 2004-12-02
US8282607B2 (en) 2012-10-09
US20040228803A1 (en) 2004-11-18
MXPA04004672A (en) 2005-03-31
EP1514539A2 (en) 2005-03-16

Similar Documents

Publication Publication Date Title
CL2004001058A1 (en) HANDLE THAT HAS A FIRST AND SECOND END AND A WALL BETWEEN BOTH THAT EXTENDS DEFINING A TUBULAR CAVITY WHOSE INSIDE SIDE CONTAINS A THERAPEUTIC SECTION THAT PRESENTS A DOSED MOISTURE CONTROL SYSTEM WITH A FARMAC COMPOSITION
ES2167061T3 (en) DOSAGE FORMS TO IMPROVE ERECTILE DYSFUNCTION IN MALE SEX PATIENTS.
CR10167A (en) "USE OF BENZO-FUSIONED SULFAMIDE DERIVATIVES FOR PAIN TREATMENT"
MX157579A (en) IMPROVEMENTS TO SURGICAL DEVICE TO BE INSERTED IN THE HUMAN BODY, WHICH HAS A LONG PROBE
CL2008003901A1 (en) Use of a hedgehog inhibitor to extend relapse-free survival in a patient with cancer, who is on chemotherapy or has previously been treated with chemotherapy.
CL2008001268A1 (en) Compounds derived from n- [6-amino-5-aryl-pyridin-2-yl] -carboxamide; pharmaceutical composition that includes them; combined pharmaceutical composition comprising them together with another additional pharmacological agent; and use them in the treatment of pain.
CL2013001136A1 (en) A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent.
CU20180125A7 (en) LIQUID FORMULATIONS OF (S) -N- (5 - ((R) -2- (2,5-DIFLUOROPHENYL) -PIRROLIDIN-1-IL) -PIRAZOLO [1,5-ALPIRIMIDIN-3-IL) -3 HYDROXIPIRROLIDINE- 1-CARBOXAMIDE
CL2004000931A1 (en) CONSUMABLE FILM ADAPTED TO ADHER AND DISSOLVE IN THE ORAL CAVITY THAT INCLUDES A MODIFIED ALMIDON AND A PHARMACEUTICALLY ACTIVE AGENT.
CO2021000174A2 (en) Topical compositions for pain relief
BRPI0707612B8 (en) sealed vessel and liquid formulations contained therein
AR029655A1 (en) IMPROVEMENTS IN FORMULATIONS IN PASTA
ATE514447T1 (en) CATHETER ASSEMBLY WITH CATHETER HANDLE AND CONTAINER
ES2183486T3 (en) FORMULATIONS OF FSH AND FSH VARIANTS THAT INCLUDE BENCILIC ALCOHOL AS A PRESERVATIVE AGENT.
PA8574001A1 (en) USE OF DOCETAXEL IN COMBINATION WITH DOXORRUBICINE AND CYCLOFOSPHAMIDE AS AN ADJUSING THERAPY
AR044932A1 (en) IMPROVED DOSING DEVICE
CL2014002706A1 (en) Vesicular formulations comprising a phospholipid and a surface active agent and the use in the treatment of pain or reduced mobility of a joint.
BR112015013819A2 (en) teeth whitening methods
AR040036A1 (en) TREATMENT OF MUCOSITIS
CL2004000877A1 (en) PHARMACEUTICAL COMBINATION THAT INCLUDES 8A) MELATONIN AND MELATONINE AGONISTS, AND NICOTINE AND NICOTINE RECEIVING AGONISTS; PHARMACEUTICAL KIT, AND; USE IN THE TREATMENT OF INSOMNIUM, COGNITIVE DIFFICULTIES AND MEMORY DIFFICULTIES; FARMACEU KIT
CL2008000227A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF ORAL USE OF TRAMADOL AND KETOPROFEN; AND USE IN THE TREATMENT OF PAIN.
PE20000532A1 (en) ABSORBING ARTICLE WITH A RAISED PORTION
BRPI0415232A (en) use of hypothermic xenon to treat neonatal asphyxia
ATE517695T1 (en) DISPENSER FOR LIQUID OR GEL PRODUCTS
AR045392A1 (en) COMPOSITIONS FOR HAIR TREATMENT